Sign up to save your podcasts
Or
Share Monte Rosa Therapeutics' CEO Markus Warmuth updates us on the company's progress in developing molecular glue degraders
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Monte Rosa Therapeutics' CEO Markus Warmuth updates us on the company's progress in developing molecular glue degraders
The company, which recently had a paper earn a spot on the cover of Science, is progressing ahead with both I&I and oncology indications. Dr. Warmuth walks us through the pipeline progress and overall strategy of finding and pursuing targets.
View all episodes
By BiotechTV
5
44 ratings
The company, which recently had a paper earn a spot on the cover of Science, is progressing ahead with both I&I and oncology indications. Dr. Warmuth walks us through the pipeline progress and overall strategy of finding and pursuing targets.
More shows like BiotechTV - News
View all
Planet Money
30,642 Listeners
Odd Lots
1,874 Listeners
a16z Podcast
1,087 Listeners
The Readout Loud
325 Listeners
The Journal.
6,092 Listeners
Biotech 2050 Podcast
60 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,862 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
19 Listeners
ACQ2 by Acquired
261 Listeners
BG2Pod with Brad Gerstner and Bill Gurley
504 Listeners
The Studio at Kendall Square
0 Listeners
Off-Target Effects with Matt Gline
4 Listeners
Biotech CEO Sisterhood
2 Listeners
BioVenture VoiCes with Chris Garabedian
6 Listeners